Covance history

Corning Lab Services expanded its clinical trials expertise with the purchase of Philadelphia Association of Clinical Trials (PACT) Inc. in 1990.

In 1991 it added to its roster SciCor Inc., an Indianapolis-based laboratory dedicated to clinical trials of new pharmaceutical compounds.

Besselaar was the world's largest contract clinical research organization by the end of 1992.

In 1993 Corning combined Hazleton, Besselaar, and SciCor into a single operating unit, Corning Pharmaceutical Services.

The parent subsidiary, Corning Lab Services, was renamed Corning Life Sciences, Inc. in 1994.

In 1995 this subsidiary acquired National Packaging Systems, Inc., a pharmaceuticals packaging company.

In March 1996 the unit purchased Health Technology Associates Inc., a Washington, D.C., consulting firm specializing in conducting cost-effectiveness studies for new drugs.

The plant it opened there in 1997 was the biggest biotechnology facility in the world devoted exclusively to outsourcing.

Covance, in November 1998, acquired GDXI, Inc., providing centralized electrocardiogram analysis for clinical trials, and Berkeley Antibody Co., providing contract services and custom animal research, antibody production, and applied immunology.

In April 1999 Covance announced that it had reached an agreement to acquire Parexel International Corp., the world's third largest clinical trials company, for stock valued at $671 million.

2000 National Genetics Institute LabCorp acquires Los Angeles-based National Genetics Institute, allowing LabCorp to gain NGI’s ultra-sensitive hepatitis C testing capability.

2001 ViroMed acquisition ViroMed, one of the leading laboratories in molecular microbial testing using real-time PCR platforms, becomes a part of LabCorp.

2002 LabCorp acquires Dynacare With the acquisition of Dynacare, LabCorp expands its geographic presence in the western and midwestern United States, as well as creating LabCorp’s first significant international presence in Canada.

2003 DIANON Systems becomes part of LabCorp LabCorp continues to build the most robust anatomic pathology capabilities in the world by acquiring DIANON Systems, now Dianon Pathology.

2005 LabCorp acquires Esoterix, Inc. and US LABS Both Esoterix, Inc. and US LABS become part of the LabCorp family.

2006 Litholink becomes part of LabCorp LabCorp acquires Litholink, a leading provider of testing that provides targeted treatment information, helping physicians better manage and prevent chronic diseases, including kidney stones and chronic kidney disease.

2008 Tandem Laboratories purchased by LabCorp LabCorp expands its clinical trials, personalized medicine, and companion diagnostic capabilities by purchasing Tandem Laboratories.

2009 Monogram Biosciences is purchased by LabCorp LabCorp purchases Monogram Biosciences, a recognized leader in the discovery and commercialization of products to guide and improve the treatment of HIV, cancer, and other serious diseases.

2010 LabCorp finalizes acquisition of Genzyme Genetics LabCorp completes its $1 billion acquisition of Genzyme Genetics, a business unit of Genzyme Corporation.

2011 Orchid Cellmark, Inc. becomes part of LabCorp LabCorp acquires Orchid Cellmark, Inc. (Orchid), harmonizing two experienced and highly qualified forensics and family relationship laboratories.

2012 is a big year for the LabCorp brand.

2014 Two new additions to LabCorp LabCorp acquires LipoScience, Inc., a provider of specialized cardiovascular diagnostic lab tests based on nuclear magnetic resonance (NMR) technology.

2015 Acquisition of Covance headlines a banner year In February 2015, LabCorp completes its $6 billion purchase of Covance, Inc., creating the world’s leading health care diagnostics company.

2016 LabCorp acquires Sequenom LabCorp successfully completes the acquisition of Sequenom, a leader in non invasive prenatal testing (NIPT), women’s health and reproductive testing, and other services.

2017 LabCorp acquires Chiltern, PAML and Mount Sinai’s Clinical Outreach Laboratories Chiltern becomes part of the company’s Covance Drug Development business.

2019 LabCorp acquires MNG Laboratories On March 1, 2019, LabCorp acquires MNG Laboratories, an internationally recognized clinical diagnostic leader that specializes in next generation sequencing (NGS) and complex biochemical testing for neurology.